ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

PeopleandPicks.com is Zacks' Community Website
Find great stocks and great stock pickers in our online community. It's social, it's profitable and it's Free! Join the fun at PeopleandPicks.com

Quote:

Search for Ticker

Free Membership

Search:

BCR: Bard C R Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

BARD C R INC (NYSE)
BCR	81.00	0.28	(0.35%)	Vol. 768,677	16:00 ET

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas.

General Information

BARD C R INC

730 Central Avenue Murray Hill, NJ 07974 Phone: 908-277-8000 Fax: 908-277-8078 Web: www.crbard.com Email: investorrelations.crbard.com

Industry	MED/DENTAL-SUPP
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	01/28/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	80.72
52 Week High	88.43
52 Week Low	68.94
Beta	0.23
20 Day Moving Average	796,774.63
Target Price Consensus	82.62

% Price Change
4 Week	5.19
12 Week	0.51
YTD	-4.20

% Price Change Relative to S&P 500
4 Week	4.05
12 Week	-5.24
YTD	-20.72

Share Information
Shares Outstanding (millions)	97.62
Market Capitalization (millions)	7,879.65
Short Ratio	3.39
Last Split Date	06/01/2004

Dividend Information
Dividend Yield	0.84%
Annual Dividend	$0.68
Payout Ratio	0.14
Change in Payout Ratio	-0.02
Last Dividend Payout / Amount	10/22/2009 / $0.17

EPS Information
Current Quarter EPS Consensus Estimate	1.34
Current Year EPS Consensus Estimate	5.05
Estimated Long-Term EPS Growth Rate	13.70
Next EPS Report Date	01/28/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.07
30 Days Ago	2.31
60 Days Ago	2.31
90 Days Ago	2.42

Fundamental Ratios

P/E
Current FY Estimate:	15.99
Trailing 12 Months:	16.47
PEG Ratio	1.17

EPS Growth
vs. Previous Year	19.09%
vs. Previous Quarter	6.50%

Sales Growth
vs. Previous Year	3.27%
vs. Previous Quarter:	1.99%

Price Ratios
Price/Book	3.64
Price/Cash Flow	14.64
Price / Sales	3.16

ROE
09/30/09	23.76
06/30/09	23.51
03/31/09	23.56

ROA
09/30/09	18.03
06/30/09	17.71
03/31/09	17.65

Current Ratio
09/30/09	5.88
06/30/09	5.43
03/31/09	5.75

Quick Ratio
09/30/09	4.63
06/30/09	4.25
03/31/09	4.58

Operating Margin
09/30/09	19.83
06/30/09	19.30
03/31/09	18.90

Net Margin
09/30/09	27.04
06/30/09	26.26
03/31/09	24.52

Pre-Tax Margin
09/30/09	27.04
06/30/09	26.26
03/31/09	24.52

Book Value
09/30/09	22.15
06/30/09	21.17
03/31/09	20.80

Inventory Turnover
09/30/09	3.20
06/30/09	3.23
03/31/09	3.32

Debt-to-Equity
09/30/09	0.07
06/30/09	0.07
03/31/09	0.07

Debt to Capital
09/30/09	6.48
06/30/09	6.65
03/31/09	6.71


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research